EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development

Eva M Jansen iD, Luke van der Koog iD, Robin A B Elferink, Karim Rafie iD, Anika Nagelkerke iD, Reinoud Gosens iD, Henderik W Frijlink iD, Wouter L J Hinrichs iD

Small · 2026-03 · 22 (16)

DOI: 10.1002/smll.202411096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 13.02.2025. Verfasst von Eva M Jansen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of …. Hauptthemen laut MEDLINE: Extracellular Vesicles, Dry Powder Inhalers. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Astma Bestrijding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, with a significant impact on low‐ and middle‐income countries, making it a critical challenge for global health equity and sustainable development goals. Extracellular vesicles (EVs) are emerging as a promising treatment for COPD, but conventional storage at −80 °C limits their global accessibility. This study explores alternative storage methods to enhance EV stability and accessibility, particularly in low‐resource settings. EVs from lung fibroblasts are subjected to freezing, freeze drying, and spray drying with inulin or mannitol. The biophysical properties are evaluated by their capacity to support lung organoid formation. Inulin proves effective in stabilizing EVs, maintaining functionality after freezing at −20 °C for 12 weeks. Freeze drying with inulin preserves EV stability at 20 °C and 43% relative humidity. In contrast, EVs with mannitol exhibit aggregation and reduce bio‐functionality. Additionally, spray drying EVs with inulin and leucine produces a dry powder suitable for inhalation, maintaining biophysical properties and functionality for 12 weeks. The powder demonstrates efficient lung deposition using the Cyclops inhaler. These findings suggest inulin as a stabilizer for EVs, eliminating the need for ultra‐low temperature storage and improving the practicality of EV‐based inhalable therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesDry Powder InhalersPowdersHumansFreeze DryingInulinAdministration, InhalationMannitolLungFibroblasts

Stichwörter der Autor:innen

inulinlung fibroblastslyophilizationmannitolorganoidsprocess stabilitystorage stability

Substanzen

PowdersInulinMannitol

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology and Biopharmacy, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, 9713 AV, The Netherlands.
  • Department of Molecular Pharmacology, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, 9713 AV, The Netherlands.
  • GRIAC, Groningen Research Institute for Asthma and COPD, University Medical Center Groningen, Groningen, 9713 GZ, The Netherlands.
  • Department of Pharmaceutical Analysis, Groningen Research Institute of Pharmacy, Faculty of Science and Engineering, University of Groningen, Groningen, 9713 AV, The Netherlands.

ORCID-Profile: Eva M Jansen, Luke van der Koog, Karim Rafie, Anika Nagelkerke, Reinoud Gosens, Henderik W Frijlink, Wouter L J Hinrichs

Förderung

  • Stichting Astma Bestrijding

Zitieren

APA

Jansen, E. M., van der Koog, L., Elferink, R. A. B., Rafie, K., Nagelkerke, A., Gosens, R., Frijlink, H. W., & Hinrichs, W. L. J. (2026). Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development. Small, 22(16). https://doi.org/10.1002/smll.202411096

Vancouver

Jansen EM, van der Koog L, Elferink RAB, Rafie K, Nagelkerke A, Gosens R, et al. Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development. Small. 2026;22(16). doi:10.1002/smll.202411096

BibTeX
@article{Jansen2026,
  author = {Jansen, Eva M and van der Koog, Luke and Elferink, Robin A B and Rafie, Karim and Nagelkerke, Anika and Gosens, Reinoud and Frijlink, Henderik W and Hinrichs, Wouter L J},
  title = {Stabilized Extracellular Vesicle Formulations for Inhalable Dry Powder Development},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {16},
  doi = {10.1002/smll.202411096}
}
Kostenlos starten →